Hostname: page-component-89b8bd64d-j4x9h Total loading time: 0 Render date: 2026-05-09T09:04:49.432Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinicoradiological characteristics of patients with differentiated thyroid carcinoma and renal metastasis: case series with follow up

Published online by Cambridge University Press:  30 January 2014

P Kand  and
S Basu
P Kand
Affiliation:
Radiation Medicine Centre (BARC), Tata Memorial Centre Annexe, Mumbai, India
S Basu*
Affiliation:
Radiation Medicine Centre (BARC), Tata Memorial Centre Annexe, Mumbai, India
*
Address for correspondence: Dr Sandip Basu, Radiation Medicine Centre (BARC), T M C Annexe, Jerbai Wadia Rd, Parel, Mumbai 400012, India Fax: +91 (0)22 24157098 E-mail: drsanb@yahoo.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Renal metastasis is relatively unusual in patients with differentiated thyroid carcinoma.

Methods:

The clinicoradiological parameters of a series of patients with differentiated thyroid carcinoma and renal metastasis were assessed, together with follow-up data.

Results and conclusion:

The series comprised 4 male patients over the age of 45 years with extensive disease at the primary site. Retro-sternal extension of a large goitre was observed in three patients. The primary tumour was 4 cm or larger in all patients (range, 4–14 cm), and three patients had associated lymph node metastasis. None had any genito-urinary symptoms at presentation. Two patients had isolated renal metastases with no other distant metastases, while the others had extensive multi-organ involvement. The bilateral occurrence of lesions was a hallmark, being observed in all cases. Ultrasound-guided fine needle aspiration cytology and 131I scintigraphy were pivotal in confirming the diagnosis. Evidence of ‘flip-flop’ between 131I study and fluoro-deoxyglucose positron emission tomography was noted in one patient, while the other three demonstrated concordant lesions in both modalities. At a minimum follow-up period of four years after diagnosis, three patients demonstrated stable disease with radioiodine therapy, and one had expired due to a poorly differentiated lung carcinoma which developed subsequently.

Keywords

Thyroid CarcinomaNeoplasm MetastasisKidneyFluorodeoxyglucose F18Positron Emission TomographyTomographyX-Ray Computed

Information

Type
Clinical Records
Information
The Journal of Laryngology & Otology , Volume 128 , Issue 2 , February 2014 , pp. 203 - 208
Copyright
Copyright © JLO (1984) Limited 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1Sampson, E, Brierley, JD, Le, LW, Rotstein, L, Tsang, RW. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer 2007;110:1451–6Google Scholar
2Graham, LD, Roe, SM. Metastatic papillary thyroid carcinoma presenting as a primary renal neoplasm. Am Surg 1995;61:732–4Google Scholar
3Borde, C, Basu, S, Kand, P, Arya, S, Shet, T. Bilateral renal metastases from papillary thyroid carcinoma on post 131I treatment scan: flip-flop sign, radioiodine SPET, 18F-FDG PET, CECT and histopathological correlation. Hell J Nucl Med 2011;14:72–3Google Scholar
4Moudouni, SM, En-Nia, I, Rioux-Leclerq, N, Manunta, A, Guille, F, Lobel, B. Follicular carcinoma of the thyroid metastasis to the kidney nine years after resection of the primary tumour. Ann Urol (Paris) 2002;36:36–7Google Scholar
5Johnson, MW, Morettin, LB, Sarles, HE, Zaharopoulos, P. Follicular carcinoma of the thyroid metastatic to the kidney 37 years after resection of the primary tumour. J Urol 1982;127:114–16CrossRefGoogle Scholar
6Davis, RI, Corson, JM. Renal metastases from well differentiated follicular thyroid carcinoma: a case report with light and electron microscopic findings. Cancer 1979;43:265–8Google Scholar
7Phan, HT, Jager, PL, van der Wal, JE, Sluiter, WJ, Plukker, JT, Dierckx, RA et al. The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation. Eur J Endocrinol 2008;158:77–83CrossRefGoogle ScholarPubMed
8Eustatia-Rutten, CF, Smit, JW, Romijn, JA, van der Kleij-Corssmit, EP, Pereira, AM, Stokkel, MP et al. Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis. Clin Endocrinol (Oxf) 2004;6:61–74Google Scholar
9Kumar, A, Nadig, M, Patra, V, Srivastava, DN, Verma, K, Bal, CS. Adrenal and renal metastases from follicular thyroid cancer. Br J Radiol 2005;78:1038–41Google Scholar
10Nemec, J, Robling, S, Zamrazil, V, Pohunkova, D. Comparison of the distribution of diagnostic and thyroablative 1-131 in the evaluation of differentiated thyroid cancers. J Nucl Med 1979;20:92–7Google Scholar
11Spies, WG, Wojtowicz, CH, Spies, SM, Shah, AY, Zimmer, AM. Value of post-therapy whole-body I-131 imaging in the evaluation of patients with thyroid carcinoma having undergone high dose I-131 therapy. Clin Nucl Med 1989;14:793–800Google Scholar
12Smallridge, RC, Castro, MR, Morris, JC, Young, PR, Reynolds, JC, Merino, MJ et al. Renal metastases from thyroid papillary carcinoma: study of sodium iodide symporter expression. Thyroid 2001;11:795–804CrossRefGoogle ScholarPubMed